Log in to your Inderes Free account to see all free content on this page.
Vaxxa
0.56 SEK
-1.06 %
Less than 1K followers
VAXXA
Spotlight Stock Market
Software
Technology
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vaxxa
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 1.5 | 0.6 | 4.7 | 45.7 | 54.9 | 77.0 | 75.2 |
| growth-% | -58.7 % | 644.5 % | 862.2 % | 20.2 % | 40.2 % | -2.4 % | |
| EBITDA | -4.5 | -5.5 | -5.3 | -2.7 | -3.1 | 2.4 | -1.9 |
| EBIT | -4.7 | -7.4 | -7.9 | -46.1 | -4.3 | 0.3 | -4.2 |
| Profit before taxes | -4.7 | -7.4 | -12.5 | -50.8 | -5.1 | 0.4 | -4.1 |
| Net income | -4.7 | -7.4 | -12.8 | -51.1 | -5.1 | 0.4 | -4.1 |
| EPS | -18.64 | -5.37 | -5.28 | -6.93 | 0.00 | 0.01 | -0.10 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | 0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -294.2 % | -866.2 % | -111.4 % | -6.0 % | -5.6 % | 3.1 % | -2.5 % |
| EBIT-% | -305.0 % | -1,166.3 % | -166.7 % | -100.9 % | -7.9 % | 0.4 % | -5.6 % |
| ROE | -300.6 % | -75.9 % | -130.7 % | -456.0 % | -50.7 % | 2.0 % | -20.5 % |
| ROI | -144.1 % | -66.1 % | -111.8 % | -239.8 % | -28.7 % | 1.4 % | -16.2 % |
Login required
This content is only available for logged in users